{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:42:14Z","timestamp":1790883734520,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12325-026-03561-z","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:04:05Z","timestamp":1774857845000},"page":"2783-2794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of Four-Factor Prothrombin Complex Concentrate Versus Plasma in Patients on Vitamin\u00a0K Antagonists Undergoing Urgent Orthopedic Surgery: A Post Hoc Analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Michelle","family":"Kincaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dybdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"3561_CR1","doi-asserted-by":"publisher","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e326S\u2013e350.","journal-title":"Chest"},{"key":"3561_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","volume":"76","author":"GF Tomaselli","year":"2020","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A, et al. 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the american college of cardiology solution set oversight committee. J Am Coll Cardiol. 2020;76:594\u2013622.","journal-title":"J Am Coll Cardiol"},{"key":"3561_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.annemergmed.2019.09.001","volume":"76","author":"CW Baugh","year":"2020","unstructured":"Baugh CW, Levine M, Cornutt D, et al. Anticoagulant reversal strategies in the emergency department setting: recommendations of a multidisciplinary expert panel. Ann Emerg Med. 2020;76:470\u201385.","journal-title":"Ann Emerg Med"},{"key":"3561_CR4","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1053\/j.jvca.2021.02.024","volume":"35","author":"JR Navas-Blanco","year":"2021","unstructured":"Navas-Blanco JR, Martini A, Fabbro M 2nd. Expert Consensus Decision Pathway of the American College of Cardiology on management of bleeding in patients with oral anticoagulants: A review of the 2020 update for perioperative physicians. J Cardiothorac Vasc Anesth. 2021;35:2471\u20139.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"3561_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","volume":"83","author":"RD Acosta","year":"2016","unstructured":"Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83:3\u201316.","journal-title":"Gastrointest Endosc"},{"key":"3561_CR6","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2022;53:e282\u2013361.","journal-title":"Stroke"},{"key":"3561_CR7","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","volume":"2","author":"DM Witt","year":"2018","unstructured":"Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2:3257\u201391.","journal-title":"Blood Adv"},{"key":"3561_CR8","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/CCM.0000000000002057","volume":"44","author":"JA Frontera","year":"2016","unstructured":"Frontera JA, Lewin JJ 3rd, Rabinstein AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: executive summary. A statement for healthcare professionals from the Neurocritical Care Society and the Society of Critical Care Medicine. Crit Care Med. 2016;44:2251\u20137.","journal-title":"Crit Care Med"},{"key":"3561_CR9","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1182\/blood.V124.21.1472.1472","volume":"124","author":"E Herzog","year":"2014","unstructured":"Herzog E, Kaspereit F, Krege W, Niebl P, Schulte S, Dickneite G. Four-factor prothrombin complex concentrate (4F-PCC) is superior to three-factor prothombin comlex concentrates (3F-PCC) for reversal of coumarin anticoagulation. Blood. 2014;124:1472.","journal-title":"Blood"},{"key":"3561_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1537-2995.2011.03247.x","volume":"52","author":"C Narick","year":"2012","unstructured":"Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion. 2012;52:160\u20135.","journal-title":"Transfusion"},{"key":"3561_CR11","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1111\/trf.13191","volume":"55","author":"MA Refaai","year":"2015","unstructured":"Refaai MA, Goldstein JN, Lee ML, Durn BL, Milling TJ Jr., Sarode R. Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin\u00a0K antagonist reversal. Transfusion. 2015;55:2722\u20139.","journal-title":"Transfusion"},{"key":"3561_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/j.1537-2995.2010.02630.x","volume":"50","author":"MH Murad","year":"2010","unstructured":"Murad MH, Stubbs JR, Gandhi MJ, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion. 2010;50:1370\u201383.","journal-title":"Transfusion"},{"key":"3561_CR13","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1378\/chest.06-3048","volume":"131","author":"H Khan","year":"2007","unstructured":"Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007;131:1308\u201314.","journal-title":"Chest"},{"key":"3561_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.5811\/westjem.2018.5.38235","volume":"20","author":"J Yee","year":"2019","unstructured":"Yee J, Kaide CG. Emergency reversal of anticoagulation. West J Emerg Med. 2019;20:770\u201383.","journal-title":"West J Emerg Med"},{"key":"3561_CR15","doi-asserted-by":"publisher","first-page":"e152S","DOI":"10.1378\/chest.11-2295","volume":"141","author":"A Holbrook","year":"2012","unstructured":"Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e152S\u2013e184.","journal-title":"Chest"},{"key":"3561_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40268-015-0088-6","volume":"15","author":"T Purmonen","year":"2015","unstructured":"Purmonen T, T\u00f6rm\u00e4lehto S, S\u00e4\u00e4vuori N, Kokki H. Budget impact analysis of warfarin reversal therapies among hip fracture patients in Finland. Drugs R D. 2015;15:155\u201362.","journal-title":"Drugs R D"},{"key":"3561_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.injury.2009.01.010","volume":"40","author":"SK Khan","year":"2009","unstructured":"Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ. Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury. 2009;40:692\u20137.","journal-title":"Injury"},{"key":"3561_CR18","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(14)61685-8","volume":"385","author":"JN Goldstein","year":"2015","unstructured":"Goldstein JN, Refaai MA, Milling TJ Jr, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin\u00a0K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase\u00a03b, open-label, non-inferiority, randomised trial. Lancet. 2015;385:2077\u201387.","journal-title":"Lancet"},{"key":"3561_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/bmj.315.7102.221","volume":"315","author":"CE De Laet","year":"1997","unstructured":"De Laet CE, van Hout BA, Burger H, Hofman A, Pols HA. Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ. 1997;315:221\u20135.","journal-title":"BMJ"},{"key":"3561_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10195-013-0274-7","volume":"15","author":"I Ahmed","year":"2014","unstructured":"Ahmed I, Khan MA, Nayak V, Mohsen A. An evidence-based warfarin management protocol reduces surgical delay in hip fracture patients. J Orthop Traumatol. 2014;15:21\u20137.","journal-title":"J Orthop Traumatol"},{"key":"3561_CR21","first-page":"490","volume":"10","author":"MA Ghasemi","year":"2022","unstructured":"Ghasemi MA, Ghadimi E, Shamabadi A, Mortazavi SJ. The perioperative management of antiplatelet and anticoagulant drugs in hip fractures: do the surgery as early as possible. Arch Bone Jt Surg. 2022;10:490\u2013500.","journal-title":"Arch Bone Jt Surg"},{"key":"3561_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/BF03016088","volume":"55","author":"T Shiga","year":"2008","unstructured":"Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth. 2008;55:146\u201354.","journal-title":"Can J Anaesth"},{"key":"3561_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231179682","volume":"29","author":"MA Refaai","year":"2023","unstructured":"Refaai MA, Bajcic P, McNeill R, Hood C, Milling TJ. Retrospective analysis of the real-world utilization of 4-factor prothrombin complex concentrate and plasma in oral anticoagulant-associated bleeding in US hospitals. Clin Appl Thromb Hemost. 2023;29:10760296231179682.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3561_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","volume":"128","author":"R Sarode","year":"2013","unstructured":"Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin\u00a0K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase\u00a0IIIb study. Circulation. 2013;128:1234\u201343.","journal-title":"Circulation"},{"key":"3561_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1503\/cjs.018017","volume":"62","author":"R Ng","year":"2019","unstructured":"Ng R, Shabani-Rad MT. Results of Octaplex for reversal of warfarin anticoagulation in patients with hip fracture. Can J Surg. 2019;62:14\u20139.","journal-title":"Can J Surg"},{"issue":"6","key":"3561_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1586\/ehm.11.59","volume":"4","author":"C Patriquin","year":"2011","unstructured":"Patriquin C, Crowther M. Treatment of warfarin-associated coagulopathy with vitamin\u00a0K. Expert Rev Hematol. 2011;4(6):657\u201365.","journal-title":"Expert Rev Hematol"},{"key":"3561_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/phar.1270","volume":"33","author":"JL Thigpen","year":"2013","unstructured":"Thigpen JL, Limdi NA. Reversal of oral anticoagulation. Pharmacotherapy. 2013;33:1199\u2013213.","journal-title":"Pharmacotherapy"},{"key":"3561_CR28","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1182\/bloodadvances.2022009015","volume":"7","author":"C Hood","year":"2023","unstructured":"Hood C, Goldstein JN, Milling TJ, et al. INR and vitamin\u00a0K-dependent factor levels after vitamin\u00a0K antagonist reversal with 4F-PCC or plasma. Blood Adv. 2023;7:2206\u201313.","journal-title":"Blood Adv"},{"key":"3561_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0019-5413.73660","volume":"45","author":"N Simunovic","year":"2011","unstructured":"Simunovic N, Devereaux PJ, Bhandari M. Surgery for hip fractures: does surgical delay affect outcomes? Indian J Orthop. 2011;45:27\u201332.","journal-title":"Indian J Orthop"},{"key":"3561_CR30","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1001\/jama.291.14.1738","volume":"291","author":"GM Orosz","year":"2004","unstructured":"Orosz GM, Magaziner J, Hannan EL. Association of timing of surgery for hip fracture and patient outcomes. JAMA. 2004;291:1738\u201343.","journal-title":"JAMA"},{"key":"3561_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/acem.12911","volume":"23","author":"TJ Milling Jr.","year":"2016","unstructured":"Milling TJ Jr., Refaai MA, Sarode R, et al. Safety of a four-factor prothrombin complex concentrate versus plasma for vitamin\u00a0K antagonist reversal: an integrated analysis of two phase\u00a0IIIb clinical trials. Acad Emerg Med. 2016;23:466\u201375.","journal-title":"Acad Emerg Med"},{"key":"3561_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1537-2995.2010.02816.x","volume":"51","author":"G Li","year":"2011","unstructured":"Li G, Rachmale S, Kojicic M, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011;51:338\u201343.","journal-title":"Transfusion"},{"key":"3561_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-018-2126-3","volume":"19","author":"L Mattisson","year":"2018","unstructured":"Mattisson L, Lapidus LJ, Enocson A. Is fast reversal and early surgery (within 24\u00a0h) in patients on warfarin medication with trochanteric hip fractures safe? A case-control study. BMC Musculoskelet Disord. 2018;19:203.","journal-title":"BMC Musculoskelet Disord"},{"key":"3561_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/11207000221148096","volume":"33","author":"KL Mekkawy","year":"2023","unstructured":"Mekkawy KL, Chaudhry YP, Mawn JG, et al. Determining a preoperative international normalised ratio threshold safe for hip fracture surgery. Hip Int. 2023;33:941\u20137.","journal-title":"Hip Int"},{"key":"3561_CR35","unstructured":"American Academy of Orthopaedic Surgeons Management of hip fractures in older adults evidence-based clinical practice guideline. https:\/\/www.aaos.org\/globalassets\/quality-and-practice-resources\/hip-fractures-in-the-elderly\/hipfxcpg.pdf. Accessed Nov 2023."},{"key":"3561_CR36","unstructured":"National Institute for Health and Care Excellence. Hip fracture: management. https:\/\/www.nice.org.uk\/guidance\/cg124\/resources\/hip-fracture-management-pdf-35109449902789. Accessed Nov 2023."},{"key":"3561_CR37","doi-asserted-by":"publisher","first-page":"E510","DOI":"10.1503\/cjs.018520","volume":"64","author":"NJ White","year":"2021","unstructured":"White NJ, Reitzel SL, Doyle-Baker D, Sabo MT, Mattiello B, Samuel TL. Management of patients with hip fracture receiving anticoagulation: what are we doing in Canada? Can J Surg. 2021;64:E510\u20135.","journal-title":"Can J Surg"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03561-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03561-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03561-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:51:48Z","timestamp":1780116708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03561-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3561"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03561-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michelle Kincaid: Speakers' bureau for CSL Behring. Andrew J. Young has nothing to disclose. Daniel Dybdahl has nothing to disclose. Benjamin C. Taylor: Consultant for and Speakers\u2019 bureau for ZimmerBiomet; consultant for Stryker; consultant for Atricure; royalties from Innomed; editorial board member of Orthobullets.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study is a post hoc analysis of a randomized controlled trial. The original study was approved by the independent ethics committees and institutional review boards of the participating centers, in accordance with local legal requirements; written informed consent was obtained from all patients. The study was performed in accordance with the Declaration of Helsinki of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}